GRAIL (GRAL) Stock Forecast, Price Target & Predictions
GRAL Stock Forecast
GRAIL (GRAL) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $88.00, with a high of $130.00 and a low of $60.00. This represents a 73.30% increase from the last price of $50.78.
GRAL Stock Rating
GRAIL stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
GRAL Price Target Upside V Benchmarks
| Type | Name | Upside |
|---|---|---|
| Stock | GRAIL | 73.30% |
| Sector | Healthcare Stocks | 15.45% |
| Industry | Diagnostics & Research Stocks | 27.36% |
Price Target Trends
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 5 | 10 |
| Avg Price Target | - | $93.00 | $86.70 |
| Last Closing Price | $50.78 | $50.78 | $50.78 |
| Upside/Downside | - | 83.14% | 70.74% |
Ratings Trends
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
|---|---|---|---|---|---|---|
| Apr, 26 | - | 4 | 2 | - | - | 6 |
| Mar, 26 | - | 3 | 3 | - | - | 6 |
| Feb, 26 | - | 2 | 2 | - | - | 4 |
| Jan, 26 | - | 2 | 2 | - | - | 4 |
| Dec, 25 | - | 2 | 2 | - | - | 4 |
Analyst Price Target Forecasts
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Feb 24, 2026 | Kallum Titchmarsh | Morgan Stanley | $60.00 | $43.03 | 39.44% | 18.16% |
| Feb 20, 2026 | Catherine Ramsey Schulte | Robert W. Baird | $82.00 | $101.53 | -19.24% | 61.48% |
| Feb 20, 2026 | Canaccord Genuity | $80.00 | $101.53 | -21.21% | 57.54% | |
| Feb 17, 2026 | Robert W. Baird | $113.00 | $97.50 | 15.90% | 122.53% | |
| Jan 26, 2026 | Guggenheim | $130.00 | $107.58 | 20.84% | 156.01% | |
| Dec 01, 2025 | Morgan Stanley | $110.00 | $98.27 | 11.94% | 116.62% | |
| Nov 12, 2025 | Subbu Nambi | Guggenheim | $100.00 | $83.39 | 19.92% | 96.93% |
| Oct 22, 2025 | Kyle Mikson | Canaccord Genuity | $85.00 | $78.28 | 8.58% | 67.39% |
| Oct 03, 2025 | UBS | $75.00 | $64.73 | 15.87% | 47.70% | |
| Apr 21, 2025 | Canaccord Genuity | $32.00 | $26.42 | 21.12% | -36.98% |
Analyst Rating Forecasts
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Feb 20, 2026 | Cowen & Co. | Hold | Hold | hold |
| Feb 19, 2026 | Cowen & Co. | Hold | initialise | |
| Jan 26, 2026 | Guggenheim | Buy | Buy | hold |
| Nov 12, 2025 | Guggenheim | Neutral | Buy | upgrade |
| Oct 17, 2024 | Guggenheim | Neutral | initialise |
Financial Forecast
EPS Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-63.54 | $-11.11 | - | - |
| Avg Forecast | $-65.16 | $-15.15 | $-13.81 | $-12.39 |
| High Forecast | $-62.42 | $-14.51 | $-12.95 | $-11.87 |
| Low Forecast | $-69.26 | $-16.10 | $-14.67 | $-13.17 |
| Surprise % | -2.49% | -26.67% | - | - |
Revenue Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $125.59M | $147.17M | - | - |
| Avg Forecast | $122.67M | $139.62M | $161.50M | $189.90M |
| High Forecast | $128.60M | $146.37M | $169.31M | $199.09M |
| Low Forecast | $118.71M | $135.11M | $156.28M | $183.76M |
| Surprise % | 2.38% | 5.41% | - | - |
Net Income Forecast
Annual
| Dec 24 | Dec 25 | Dec 26 | Dec 27 | |
|---|---|---|---|---|
| Reported | $-2.03B | $-408.35M | - | - |
| Avg Forecast | $-2.12B | $-475.36M | $-428.84M | $-388.76M |
| High Forecast | $-1.94B | $-450.68M | $-402.13M | $-368.58M |
| Low Forecast | $-2.15B | $-500.03M | $-455.54M | $-408.94M |
| Surprise % | -4.27% | -14.10% | - | - |